Clinical Trial Update: Individual Patient Compassionate Use of Mirdametinib

View source ↗

Summary

This clinical trial update notes an individual patient compassionate use of mirdametinib for Neurofibromatosis Type 1-Associated Plexiform Neurofibromas and His…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Histiocytic Neoplasm
• Neurofibromatosis Type 1-associated Plexiform Neurofibromas

Drugs mentioned

• Mirdametinib (mirdametinib)

Snippet

Sponsor: SpringWorks Therapeutics, Inc. | Conditions: Neurofibromatosis Type 1-Associated Plexiform Neurofibromas, Histiocytic Neoplasm | Status: AVAILABLE